Thrivent Financial for Lutherans’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-38,886
Closed -$3.86M 2306
2019
Q3
$3.86M Buy
38,886
+257
+0.7% +$24.4K 0.01% 744
2019
Q2
$3.57M Buy
38,629
+935
+2% +$88.8K 0.01% 769
2019
Q1
$3.56M Sell
37,694
-23,200
-38% -$2.03M 0.01% 764
2018
Q4
$4.06M Sell
60,894
-693,729
-92% -$51.2M 0.01% 659
2018
Q3
$67.5M Sell
754,623
-73,850
-9% -$6.53M 0.21% 112
2018
Q2
$65.8M Sell
828,473
-719,149
-46% -$59.7M 0.21% 113
2018
Q1
$138M Sell
1,547,622
-88,045
-5% -$8.45M 0.47% 48
2017
Q4
$171M Buy
1,635,667
+423,509
+35% +$47.8M 0.57% 34
2017
Q3
$177M Sell
1,212,158
-106,957
-8% -$14.6M 0.62% 31
2017
Q2
$171M Buy
1,319,115
+124,915
+10% +$15.3M 0.71% 26
2017
Q1
$149M Sell
1,194,200
-332,650
-22% -$39.8M 0.64% 28
2016
Q4
$177M Buy
1,526,850
+152,924
+11% +$17M 0.79% 19
2016
Q3
$144M Buy
1,373,926
+291,225
+27% +$31.5M 0.66% 26
2016
Q2
$107M Buy
1,082,701
+1,053,816
+3,648% +$109M 0.51% 39
2016
Q1
$2.93M Sell
28,885
-230
-0.8% -$23.7K 0.01% 761
2015
Q4
$3.49M Buy
29,115
+7,465
+34% +$864K 0.02% 697
2015
Q3
$2.34M Sell
21,650
-6,014
-22% -$746K 0.01% 752
2015
Q2
$3.2M Buy
27,664
+987
+4% +$113K 0.02% 572
2015
Q1
$3.07M Buy
26,677
+577
+2% +$68.9K 0.02% 594
2014
Q4
$2.94M Buy
26,100
+2,535
+11% +$267K 0.02% 603
2014
Q3
$2.23M Sell
23,565
-15
-0.1% -$1.35K 0.01% 655
2014
Q2
$2.02M Sell
23,580
-12,930
-35% -$983K 0.01% 702
2014
Q1
$2.55M Buy
36,510
+12,600
+53% +$998K 0.02% 542
2013
Q4
$2.02M Sell
23,910
-20
-0.1% -$1.58K 0.01% 603
2013
Q3
$1.84M Sell
23,930
-237,470
-91% -$16.6M 0.01% 601
2013
Q2
$15.3K Buy
+261,400
New +$15.7M 0.1% 218

Other funds holding CELG

Thrivent Financial for Lutherans's CELG Position: Q4 2019 in Review

Thrivent Financial for Lutherans sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 38,886 shares — an estimated $3.86M sold.

Thrivent Financial for Lutherans first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $177M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Thrivent Financial for Lutherans reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 38,886 Celgene Corp shares in Q4 2019, an estimated $3.86M.
  • Thrivent Financial for Lutherans first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Thrivent Financial for Lutherans's Celgene Corp position peaked at $177M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2019, filed 13 Feb 2020.